Orla Protein Technologies Ltd. (Orla) announces a new trastuzumab-binding protein for simplified assay of trastuzumab binding to its antigen during development and manufacture of Antibody Drug Conjugates (ADC). The trastuzumab-binding protein (ORLA254) incorporates the Her2 Continue Reading
We are experts in sticking proteins to surfaces whilst retaining near 100% function
Proteins for functionalisation of biosensors, cell culture ware, bioprocess media and more
Our protein engineering experts will help you develop new products and processes and improve existing ones
We welcome partnering and licensing enquiries for access to our technology and expertise
Since its foundation in 2003, Orla Protein Technologies has built a solid reputation in the Life Sciences Industry through cutting-edge research and a commitment to innovation. We focus upon recombinant protein design, engineering and manufacture particularly for surface applications.
We provide technology, products and bespoke contract services and are continually seeking new partnerships and collaborations. Our patented protein engineering platform, OrlaSURF, can be readily transferred, and is used commercially in a diverse range of Life Science applications such as bioanalytical devices, cell culture, bioseparations, and assay development. We enable improved performance, efficient manufacture, reproducibility, reliability, and ultimately, superior products. Read more
Latest News from Orla
Orla Protein Technologies awarded Innovate UK project to develop tools for use during checkpoint inhibitor drug development
Orla Protein Technologies is proud to announce to have been chosen as a recipient of an Innovate UK grant for the development of proteins for use in the development of anti-cancer biopharmaceuticals. The project starting Continue Reading
In the recent BioPharm International issue in April 2017, Dr Deepan Shah, Orla Protein Technologies’ Head of Protein Engineering, examined some of the challenges faced by drug developers during ADC development. He described how Orla’s Continue Reading
Orla Protein Technologies’ Industrial CASE student Tim Robson has presented his latest results on the oriented assembly of engineered outer membrane proteins on the surface of immobilised gold nanoparticles. A poster describing this work was Continue Reading
Orla Protein Technologies Ltd, a leader in the design, engineering and immobilisation of proteins for surface applications, has been granted U.K. patent No. GB2527623 to its novel protein engineering and immobilisation platform (OrlaSURF) for immobilisation Continue Reading
OrlaExplorer plates allow researchers to discover the best growth surface for their cells and then use that exact same surface reliably over a wide range of formats such as well plates, flasks and micro-carrier beads.